Summit Corporation plc Share Price London S.E.
Stocks
GB00B02T3K57
Biotechnology & Medical Research
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| Market Cap | 10.11B 13.67B 11.76B 11.06B 18.91B 1,290B 18.97B 131B 50.77B 662B 51.27B 50.19B 2,136B | P/E 2026 * |
-15.1x | P/E 2027 * | -15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 9.64B 13.03B 11.22B 10.55B 18.04B 1,231B 18.1B 125B 48.42B 631B 48.89B 47.87B 2,037B | EV / Sales 2026 * |
3,298x | EV / Sales 2027 * | 238x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Summit Corporation plc
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 55 | 24/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 31/03/2020 |
| Director of Finance/CFO | 48 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 31/01/2020 |
| Director/Board Member | 48 | 30/11/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 55 | 10/11/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | -3.82% | +38.74% | +91.90% | 69.02B | |
| -2.06% | -1.52% | +46.40% | +86.87% | 66.32B | |
| -0.31% | +4.04% | -11.99% | +457.82% | 27.66B | |
| +0.86% | -6.86% | +3.33% | -14.78% | 25.84B | |
| -3.00% | -2.61% | +34.45% | +11.39% | 26.54B | |
| -1.46% | -0.09% | +24.64% | -18.36% | 20.4B | |
| -2.96% | -16.03% | +213.13% | +375.00% | 17.63B | |
| -1.49% | -6.69% | -4.69% | +539.74% | 15.15B | |
| -0.20% | +6.79% | +59.66% | +159.50% | 14.65B | |
| Average | -1.38% | -0.66% | +44.85% | +187.68% | 31.47B | |
| Weighted average by Cap. | -1.53% | -0.45% | +40.54% | +146.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.92M 3.95M 3.4M 3.2M 5.47M 373M 5.49M 37.81M 14.68M 191M 14.82M 14.51M 618M | 41.7M 56.38M 48.54M 45.64M 78.03M 5.32B 78.29M 539M 209M 2.73B 212M 207M 8.81B |
| Net income | -690M -933M -803M -755M -1.29B -88.06B -1.3B -8.92B -3.47B -45.19B -3.5B -3.43B -146B | -730M -986M -849M -799M -1.37B -93.13B -1.37B -9.44B -3.66B -47.79B -3.7B -3.62B -154B |
| Net Debt | -467M -632M -544M -511M -874M -59.65B -877M -6.04B -2.35B -30.61B -2.37B -2.32B -98.74B | -199M -268M -231M -217M -372M -25.35B -373M -2.57B -998M -13.01B -1.01B -986M -41.96B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
